Literature DB >> 2252039

Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study.

M J Fine1, D N Smith, D E Singer.   

Abstract

PURPOSE: To identify a low-risk subset of patients with community-acquired pneumonia that could safely be treated in the ambulatory setting; and to assess how clinicians make the hospitalization decision. PATIENTS AND METHODS: We performed a prospective, observational study of 280 ambulatory and hospitalized adults with clinical and radiographic evidence of pneumonia. Patients were followed to assess all potential morbid complications and 6-week mortality. Physicians responsible for managing these patients were surveyed to assess the reasons for treating in a hospital or ambulatory setting and the therapies that dictate hospitalization.
RESULTS: Sixty-one percent (170 of 280) of patients did not have an indication for admission at presentation using modified Appropriateness Evaluation Protocol criteria (a severe vital sign abnormality, alteration in mental status, suppurative complication, arterial hypoxemia, severe laboratory abnormality, or an acute coexistent medical problem requiring admission independent of the pneumonia). Among these 170 patients, 38% had a complicated course defined as death within 6 weeks, development of a new suppurative or medical complication due to pneumonia, intensive care unit admission, persistent fever or use of intravenous fluids or oxygen beyond 3 days, hospitalization lasting more than 3 days, or subsequent hospitalization in patients initially treated in the ambulatory setting. Five predisposing factors for a complicated course were identified in logistic regression models. The odds ratio for age more than 65 years was 2.7; for comorbid illness, 3.2; for temperature more than 38.3 degrees C (101 degrees F), 4.1; for immunosuppression, 12.0; and for a high-risk etiology, 23.3. The risk of a complicated course increased linearly with the number of risk factors, from 12% with none to 100% with four or more factors (p less than 0.001). Physicians most often relied on the general clinical appearance of the patient when making the triage decision, and most commonly cited intravenous antibiotics and chest physical therapy as treatments requiring hospitalization.
CONCLUSIONS: If validated, our findings could improve physicians' assessment of prognosis, and may identify a low-risk subset of patients with community-acquired pneumonia who could safely be managed in the ambulatory setting.

Entities:  

Mesh:

Year:  1990        PMID: 2252039     DOI: 10.1016/0002-9343(90)90211-u

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  28 in total

1.  Changing the culture?

Authors:  D Jewell
Journal:  Br J Gen Pract       Date:  2001-03       Impact factor: 5.386

2.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

3.  Measuring symptomatic and functional recovery in patients with community-acquired pneumonia.

Authors:  J P Metlay; M J Fine; R Schulz; T J Marrie; C M Coley; W N Kapoor; D E Singer
Journal:  J Gen Intern Med       Date:  1997-07       Impact factor: 5.128

4.  Antimicrobial treatment of community acquired pneumonia in adults: A conference report.

Authors:  L Mandell; M Niederman
Journal:  Can J Infect Dis       Date:  1993-01

Review 5.  Drug treatment of pneumonia in the elderly: efficacy and costs.

Authors:  E Saltiel; S Weingarten
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

6.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

7.  The utility of blood culture in patients with community-acquired pneumonia.

Authors:  H I Luna; G Pankey
Journal:  Ochsner J       Date:  2001-04

8.  Do physicians do what they say? The inclination to test and its association with coronary angiography rates.

Authors:  D E Wennberg; J D Dickens; L Biener; F J Fowler; D N Soule; R B Keller
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

9.  Arterial blood gas and pulse oximetry in initial management of patients with community-acquired pneumonia.

Authors:  K P Levin; B H Hanusa; A Rotondi; D E Singer; C M Coley; T J Marrie; W N Kapoor; M J Fine
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

10.  Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia.

Authors:  M J Fine; B H Hanusa; J R Lave; D E Singer; R A Stone; L A Weissfeld; C M Coley; T J Marrie; W N Kapoor
Journal:  J Gen Intern Med       Date:  1995-07       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.